Notice: Global Information Announces Listing on JASDAQ Standard Market of the Tokyo Stock Exchange

Cover Image
Market Research Report

Global Proton Pump Inhibitors Market Insights, Forecast to 2027

Published by QYResearch Product code 998277
Published Content info 149 Pages
Delivery time: 2-3 business days
Price
Back to Top
Global Proton Pump Inhibitors Market Insights, Forecast to 2027
Published: April 2, 2021 Content info: 149 Pages
Description

Market Analysis and Insights: Global Proton Pump Inhibitors Market

The global Proton Pump Inhibitors market is valued at US$ 12813 million in 2020. The market size will reach US$ 10013 million by the end of 2027, growing at a CAGR of -3.22% during 2021-2027.

Global Proton Pump Inhibitors Scope and Segment

Proton Pump Inhibitors market is segmented by Type, and by Application. Players, stakeholders, and other participants in the global Proton Pump Inhibitors market will be able to gain the upper hand as they use the report as a powerful resource. The segmental analysis focuses on sales, revenue and forecast by Type, and by Application for the period 2016-2027.

By Company

  • Takeda
  • Pfizer
  • AstraZeneca
  • Bayer
  • Sun Pharma
  • Teva
  • Eisai Co.
  • Mylan
  • AOSAIKANG Pharma
  • Luoxin Pharma
  • LIVZON
  • Eastchina Pharma

Segment by Type

  • Dexlansoprazole
  • Esomeprazole
  • Lansoprazole
  • Omeprazole
  • Pantoprazole
  • Rabeprazole

Segment by Application

  • Hospital Pharmacy
  • Retail Pharmacy
  • Other

Segment by Region

  • North America
  • United States
  • Canada
  • Mexico
  • Asia-Pacific
  • China
  • Japan
  • South Korea
  • India
  • Southeast Asia
  • Australia
  • Europe
  • Germany
  • U.K.
  • France
  • Italy
  • Russia
  • Rest of Europe
  • Latin America
  • Brazil
  • Rest of Latin America
  • Middle East & Africa
  • Turkey
  • Saudi Arabia
  • U.A.E
  • Other Regions
Table of Contents

TABLE OF CONTENTS

1 STUDY COVERAGE

  • 1.1 Proton Pump Inhibitors Product Introduction
  • 1.2 Market by Type
    • 1.2.1 Global Proton Pump Inhibitors Market Size Growth Rate by Type
    • 1.2.2 Dexlansoprazole
    • 1.2.3 Esomeprazole
    • 1.2.4 Lansoprazole
    • 1.2.5 Omeprazole
    • 1.2.6 Pantoprazole
    • 1.2.7 Rabeprazole
  • 1.3 Market by Application
    • 1.3.1 Global Proton Pump Inhibitors Market Size Growth Rate by Application
    • 1.3.2 Hospital Pharmacy
    • 1.3.3 Retail Pharmacy
  • 1.4 Study Objectives
  • 1.5 Years Considered

2 EXECUTIVE SUMMARY

  • 2.1 Global Proton Pump Inhibitors Sales Estimates and Forecasts 2016-2027
  • 2.2 Global Proton Pump Inhibitors Revenue Estimates and Forecasts 2016-2027
  • 2.3 Global Proton Pump Inhibitors Revenue by Region: 2016 VS 2021 VS 2027
  • 2.4 Global Top Proton Pump Inhibitors Regions by Sales
    • 2.4.1 Global Top Proton Pump Inhibitors Regions by Sales (2016-2021)
    • 2.4.2 Global Top Proton Pump Inhibitors Regions by Sales (2022-2027)
  • 2.5 Global Top Proton Pump Inhibitors Regions by Revenue
    • 2.5.1 Global Top Proton Pump Inhibitors Regions by Revenue (2016-2021)
    • 2.5.2 Global Top Proton Pump Inhibitors Regions by Revenue (2022-2027)
  • 2.6 North America
  • 2.7 Europe
  • 2.8 Asia-Pacific
  • 2.9 South America
  • 2.10 Middle East & Africa

3 COMPETITION BY MANUFACTURERS

  • 3.1 Global Proton Pump Inhibitors Sales by Manufacturers
    • 3.1.1 Global Top Proton Pump Inhibitors Manufacturers by Sales (2019-2021)
    • 3.1.2 Global Top Proton Pump Inhibitors Manufacturers Market Share by Sales (2019-2021)
    • 3.1.3 Global Top 5 Companies by Proton Pump Inhibitors Sales in 2020
  • 3.2 Global Proton Pump Inhibitors Revenue by Manufacturers
    • 3.2.1 Global Top Proton Pump Inhibitors Manufacturers by Revenue (2019-2021)
    • 3.2.2 Global Top Proton Pump Inhibitors Manufacturers Market Share by Revenue (2019-2021)
    • 3.2.3 Global Top 5 Companies by Proton Pump Inhibitors Revenue in 2020
  • 3.3 Global Proton Pump Inhibitors Sales Price by Manufacturers
  • 3.4 Analysis of Competitive Landscape
    • 3.4.1 Manufacturers Market Concentration Ratio (CR5 and HHI)
    • 3.4.2 Global Proton Pump Inhibitors Market Share by Company Type (Tier 1, Tier 2, and Tier 3)
    • 3.4.3 Global Proton Pump Inhibitors Manufacturers Geographical Distribution
  • 3.5 Mergers & Acquisitions, Expansion Plans

4 MARKET SIZE BY TYPE

  • 4.1 Global Proton Pump Inhibitors Sales by Type
    • 4.1.1 Global Proton Pump Inhibitors Historical Sales by Type (2016-2021)
    • 4.1.2 Global Proton Pump Inhibitors Forecasted Sales by Type (2022-2027)
    • 4.1.3 Global Proton Pump Inhibitors Sales Market Share by Type (2016-2027)
  • 4.2 Global Proton Pump Inhibitors Revenue by Type
    • 4.2.1 Global Proton Pump Inhibitors Historical Revenue by Type (2016-2021)
    • 4.2.2 Global Proton Pump Inhibitors Forecasted Revenue by Type (2022-2027)
    • 4.2.3 Global Proton Pump Inhibitors Revenue Market Share by Type (2016-2027)
  • 4.3 Global Proton Pump Inhibitors Price by Type
    • 4.3.1 Global Proton Pump Inhibitors Price by Type (2016-2021)
    • 4.3.2 Global Proton Pump Inhibitors Price Forecast by Type (2022-2027)

5 MARKET SIZE BY APPLICATION

  • 5.1 Global Proton Pump Inhibitors Sales by Application
    • 5.1.1 Global Proton Pump Inhibitors Historical Sales by Application (2016-2021)
    • 5.1.2 Global Proton Pump Inhibitors Forecasted Sales by Application (2022-2027)
    • 5.1.3 Global Proton Pump Inhibitors Sales Market Share by Application (2016-2027)
  • 5.2 Global Proton Pump Inhibitors Revenue by Application
    • 5.2.1 Global Proton Pump Inhibitors Historical Revenue by Application (2016-2021)
    • 5.2.2 Global Proton Pump Inhibitors Forecasted Revenue by Application (2022-2027)
    • 5.2.3 Global Proton Pump Inhibitors Revenue Market Share by Application (2016-2027)
  • 5.3 Global Proton Pump Inhibitors Price by Application
    • 5.3.1 Global Proton Pump Inhibitors Price by Application (2016-2021)
    • 5.3.2 Global Proton Pump Inhibitors Price Forecast by Application (2022-2027)

6 NORTH AMERICA

  • 6.1 North America Proton Pump Inhibitors Market Size by Type
    • 6.1.1 North America Proton Pump Inhibitors Sales by Type (2016-2027)
    • 6.1.2 North America Proton Pump Inhibitors Revenue by Type (2016-2027)
  • 6.2 North America Proton Pump Inhibitors Market Size by Application
  • 6.3 North America Proton Pump Inhibitors Market Size by Country
    • 6.3.1 North America Proton Pump Inhibitors Sales by Country (2016-2027)
    • 6.3.2 North America Proton Pump Inhibitors Revenue by Country (2016-2027)
    • 6.3.3 United States
    • 6.3.4 Canada
    • 6.3.5 Mexico

7 EUROPE

  • 7.1 Europe Proton Pump Inhibitors Market Size by Type
    • 7.1.1 Europe Proton Pump Inhibitors Sales by Type (2016-2027)
    • 7.1.2 Europe Proton Pump Inhibitors Revenue by Type (2016-2027)
  • 7.2 Europe Proton Pump Inhibitors Market Size by Application
  • 7.3 Europe Proton Pump Inhibitors Market Size by Country
    • 7.3.1 Europe Proton Pump Inhibitors Sales by Country (2016-2027)
    • 7.3.2 Europe Proton Pump Inhibitors Revenue by Country (2016-2027)
    • 7.3.3 Germany
    • 7.3.4 U.K.
    • 7.3.5 France
    • 7.3.6 Italy
    • 7.3.7 Russia

8 ASIA PACIFIC

  • 8.1 Asia Pacific Proton Pump Inhibitors Market Size by Type
    • 8.1.1 Asia Pacific Proton Pump Inhibitors Sales by Type (2016-2027)
    • 8.1.2 Asia Pacific Proton Pump Inhibitors Revenue by Type (2016-2027)
  • 8.2 Asia Pacific Proton Pump Inhibitors Market Size by Application
  • 8.3 Asia Pacific Proton Pump Inhibitors Market Size by Region
    • 8.3.1 Asia Pacific Proton Pump Inhibitors Sales by Region (2016-2027)
    • 8.3.2 Asia Pacific Proton Pump Inhibitors Revenue by Region (2016-2027)
    • 8.3.3 China
    • 8.3.4 Japan
    • 8.3.5 South Korea
    • 8.3.6 India
    • 8.3.7 Southeast Asia
    • 8.3.8 Australia

9 SOUTH AMERICA

  • 9.1 South America Proton Pump Inhibitors Market Size by Type
    • 9.1.1 South America Proton Pump Inhibitors Sales by Type (2016-2027)
    • 9.1.2 South America Proton Pump Inhibitors Revenue by Type (2016-2027)
  • 9.2 South America Proton Pump Inhibitors Market Size by Application
  • 9.3 South America Proton Pump Inhibitors Market Size by Country
    • 9.3.1 South America Proton Pump Inhibitors Sales by Country (2016-2027)
    • 9.3.2 South America Proton Pump Inhibitors Revenue by Country (2016-2027)
    • 9.3.3 Brazil

10 MIDDLE EAST AND AFRICA

  • 10.1 Middle East and Africa Proton Pump Inhibitors Market Size by Type
    • 10.1.1 Middle East and Africa Proton Pump Inhibitors Sales by Type (2016-2027)
    • 10.1.2 Middle East and Africa Proton Pump Inhibitors Revenue by Type (2016-2027)
  • 10.2 Middle East and Africa Proton Pump Inhibitors Market Size by Application
  • 10.3 Middle East and Africa Proton Pump Inhibitors Market Size by Country
    • 10.3.1 Middle East and Africa Proton Pump Inhibitors Sales by Country (2016-2027)
    • 10.3.2 Middle East and Africa Proton Pump Inhibitors Revenue by Country (2016-2027)
    • 10.3.3 Turkey
    • 10.3.4 Saudi Arabia
    • 10.3.5 U.A.E

11 CORPORATE PROFILE

  • 11.1 Takeda
    • 11.1.1 Takeda Corporation Information
    • 11.1.2 Takeda Overview
    • 11.1.3 Takeda Proton Pump Inhibitors Sales, Price, Revenue and Gross Margin (2019-2021)
    • 11.1.4 Takeda Proton Pump Inhibitors Product Description
    • 11.1.5 Takeda Recent Developments
  • 11.2 Pfizer
    • 11.2.1 Pfizer Corporation Information
    • 11.2.2 Pfizer Overview
    • 11.2.3 Pfizer Proton Pump Inhibitors Sales, Price, Revenue and Gross Margin (2019-2021)
    • 11.2.4 Pfizer Proton Pump Inhibitors Product Description
    • 11.2.5 Pfizer Recent Developments
  • 11.3 AstraZeneca
    • 11.3.1 AstraZeneca Corporation Information
    • 11.3.2 AstraZeneca Overview
    • 11.3.3 AstraZeneca Proton Pump Inhibitors Sales, Price, Revenue and Gross Margin (2019-2021)
    • 11.3.4 AstraZeneca Proton Pump Inhibitors Product Description
    • 11.3.5 AstraZeneca Recent Developments
  • 11.4 Bayer
    • 11.4.1 Bayer Corporation Information
    • 11.4.2 Bayer Overview
    • 11.4.3 Bayer Proton Pump Inhibitors Sales, Price, Revenue and Gross Margin (2019-2021)
    • 11.4.4 Bayer Proton Pump Inhibitors Product Description
    • 11.4.5 Bayer Recent Developments
  • 11.5 Sun Pharma
    • 11.5.1 Sun Pharma Corporation Information
    • 11.5.2 Sun Pharma Overview
    • 11.5.3 Sun Pharma Proton Pump Inhibitors Sales, Price, Revenue and Gross Margin (2019-2021)
    • 11.5.4 Sun Pharma Proton Pump Inhibitors Product Description
  • 11.6 Teva
    • 11.6.1 Teva Corporation Information
    • 11.6.2 Teva Overview
    • 11.6.3 Teva Proton Pump Inhibitors Sales, Price, Revenue and Gross Margin (2019-2021)
    • 11.6.4 Teva Proton Pump Inhibitors Product Description
    • 11.6.5 Teva Recent Developments
  • 11.7 Eisai Co.
    • 11.7.1 Eisai Co. Corporation Information
    • 11.7.2 Eisai Co. Overview
    • 11.7.3 Eisai Co. Proton Pump Inhibitors Sales, Price, Revenue and Gross Margin (2019-2021)
    • 11.7.4 Eisai Co. Proton Pump Inhibitors Product Description
  • 11.8 Mylan
    • 11.8.1 Mylan Corporation Information
    • 11.8.2 Mylan Overview
    • 11.8.3 Mylan Proton Pump Inhibitors Sales, Price, Revenue and Gross Margin (2019-2021)
    • 11.8.4 Mylan Proton Pump Inhibitors Product Description
    • 11.8.5 Mylan Recent Developments
  • 11.9 AOSAIKANG Pharma
    • 11.9.1 AOSAIKANG Pharma Corporation Information
    • 11.9.2 AOSAIKANG Pharma Overview
    • 11.9.3 AOSAIKANG Pharma Proton Pump Inhibitors Sales, Price, Revenue and Gross Margin (2019-2021)
    • 11.9.4 AOSAIKANG Pharma Proton Pump Inhibitors Product Description
  • 11.10 Luoxin Pharma
    • 11.10.1 Luoxin Pharma Corporation Information
    • 11.10.2 Luoxin Pharma Overview
    • 11.10.3 Luoxin Pharma Proton Pump Inhibitors Sales, Price, Revenue and Gross Margin (2019-2021)
    • 11.10.4 Luoxin Pharma Proton Pump Inhibitors Product Description
    • 11.10.5 Luoxin Pharma Recent Developments
  • 11.11 LIVZON
    • 11.11.1 LIVZON Corporation Information
    • 11.11.2 LIVZON Overview
    • 11.11.3 LIVZON Proton Pump Inhibitors Sales, Price, Revenue and Gross Margin (2019-2021)
    • 11.11.4 LIVZON Proton Pump Inhibitors Product Description
  • 11.12 Eastchina Pharma
    • 11.12.1 Eastchina Pharma Corporation Information
    • 11.12.2 Eastchina Pharma Overview
    • 11.12.3 Eastchina Pharma Proton Pump Inhibitors Sales, Price, Revenue and Gross Margin (2019-2021)
    • 11.12.4 Eastchina Pharma Proton Pump Inhibitors Product Description

12 VALUE CHAIN AND SALES CHANNELS ANALYSIS

  • 12.1 Proton Pump Inhibitors Value Chain Analysis
  • 12.2 Proton Pump Inhibitors Key Raw Materials
    • 12.2.1 Key Raw Materials
    • 12.2.2 Raw Materials Key Suppliers
  • 12.3 Proton Pump Inhibitors Sales and Marketing
    • 12.3.1 Proton Pump Inhibitors Sales Channels
    • 12.3.2 Proton Pump Inhibitors Distributors
  • 12.4 Proton Pump Inhibitors Customers

13 MARKET DRIVERS, OPPORTUNITIES, CHALLENGES AND RISKS FACTORS ANALYSIS

  • 13.1 Proton Pump Inhibitors Industry Trends
  • 13.2 Proton Pump Inhibitors Market Drivers
  • 13.3 Proton Pump Inhibitors Market Challenges
  • 13.4 Proton Pump Inhibitors Market Restraints

14 KEY FINDINGS IN THE GLOBAL PROTON PUMP INHIBITORS STUDY

15 APPENDIX

  • 15.1 Research Methodology
    • 15.1.1 Methodology/Research Approach
    • 15.1.2 Data Source
  • 15.2 Author Details
  • 15.3 Disclaimer

List of Tables and Figures

  • Table 1. Global Proton Pump Inhibitors Market Size Growth Rate by Type, 2016 VS 2021 VS 2027 (US$ Million)
  • Table 2. Global Proton Pump Inhibitors Market Size Growth Rate by Application, 2016 VS 2021 VS 2027 (US$ Million)
  • Table 3. Global Proton Pump Inhibitors Revenue by Region: 2016 VS 2021 VS 2027 (US$ Million)
  • Table 4. Global Proton Pump Inhibitors Sales by Region (2016-2021) & (M Unit)
  • Table 5. Global Proton Pump Inhibitors Sales Market Share by Region (2016-2021)
  • Table 6. Global Proton Pump Inhibitors Sales Market Share by Region (2016-2021)
  • Table 7. Global Proton Pump Inhibitors Sales by Region (2022-2027) & (M Unit)
  • Table 8. Global Proton Pump Inhibitors Sales Market Share by Region (2022-2027)
  • Table 9. Global Proton Pump Inhibitors Sales Market Share by Region (2022-2027)
  • Table 10. Global Proton Pump Inhibitors Revenue by Region (2016-2021) & (US$ Million)
  • Table 11. Global Proton Pump Inhibitors Revenue Market Share by Region (2016-2021)
  • Table 12. Global Proton Pump Inhibitors Revenue by Region (2022-2027) & (US$ Million)
  • Table 13. Global Proton Pump Inhibitors Revenue Market Share by Region (2022-2027)
  • Table 14. Global Proton Pump Inhibitors Sales by Manufacturers (2019-2021) & (M Unit)
  • Table 15. Global Proton Pump Inhibitors Sales Share by Manufacturers (2019-2021)
  • Table 16. Global Proton Pump Inhibitors Revenue by Manufacturers (2019-2021) & (US$ Million)
  • Table 17. Global Proton Pump Inhibitors Revenue Share by Manufacturers (2019-2021)
  • Table 18. Proton Pump Inhibitors Price by Manufacturers 2019-2021 (USD/Unit)
  • Table 19. Global Proton Pump Inhibitors Manufacturers Market Concentration Ratio (CR5 and HHI)
  • Table 20. Global Proton Pump Inhibitors by Company Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in Proton Pump Inhibitors as of 2020)
  • Table 21. Proton Pump Inhibitors Manufacturing Base Distribution and Headquarters
  • Table 22. Manufacturers Proton Pump Inhibitors Product Offered
  • Table 23. Founded Date of Proton Pump Inhibitors Manufacturers
  • Table 24. Mergers & Acquisitions, Expansion Plans
  • Table 25. Global Proton Pump Inhibitors Sales by Type (2016-2021) & (M Unit)
  • Table 26. Global Proton Pump Inhibitors Sales by Type (2022-2027) & (M Unit)
  • Table 27. Global Proton Pump Inhibitors Sales Share by Type (2016-2021)
  • Table 28. Global Proton Pump Inhibitors Sales Share by Type (2022-2027)
  • Table 29. Global Proton Pump Inhibitors Revenue by Type (2016-2021) & (US$ Million)
  • Table 30. Global Proton Pump Inhibitors Revenue by Type (2022-2027) & (US$ Million)
  • Table 31. Global Proton Pump Inhibitors Revenue Share by Type (2016-2021)
  • Table 32. Global Proton Pump Inhibitors Revenue Share by Type (2022-2027)
  • Table 33. Proton Pump Inhibitors Price by Type (2016-2021) & (USD/Unit)
  • Table 34. Global Proton Pump Inhibitors Price Forecast by Type (2022-2027) & (USD/Unit)
  • Table 35. Global Proton Pump Inhibitors Sales by Application (2016-2021) & (M Unit)
  • Table 36. Global Proton Pump Inhibitors Sales by Application (2022-2027) & (M Unit)
  • Table 37. Global Proton Pump Inhibitors Sales Share by Application (2016-2021)
  • Table 38. Global Proton Pump Inhibitors Sales Share by Application (2022-2027)
  • Table 39. Global Proton Pump Inhibitors Revenue by Application (2016-2021) & (US$ Million)
  • Table 40. Global Proton Pump Inhibitors Revenue by Application (2022-2027) & (US$ Million)
  • Table 41. Global Proton Pump Inhibitors Revenue Share by Application (2016-2021)
  • Table 42. Global Proton Pump Inhibitors Revenue Share by Application (2022-2027)
  • Table 43. Proton Pump Inhibitors Price by Application (2016-2021) & (USD/Unit)
  • Table 44. Global Proton Pump Inhibitors Price Forecast by Application (2022-2027) & (USD/Unit)
  • Table 45. North America Proton Pump Inhibitors Sales by Type (2016-2021) & (M Unit)
  • Table 46. North America Proton Pump Inhibitors Sales by Type (2022-2027) & (M Unit)
  • Table 47. North America Proton Pump Inhibitors Revenue by Type (2016-2021) & (US$ Million)
  • Table 48. North America Proton Pump Inhibitors Revenue by Type (2022-2027) & (US$ Million)
  • Table 49. North America Proton Pump Inhibitors Revenue by Application (2016-2021) & (US$ Million)
  • Table 50. North America Proton Pump Inhibitors Revenue by Application (2022-2027) & (US$ Million)
  • Table 51. North America Proton Pump Inhibitors Sales by Country (2016-2021) & (M Unit)
  • Table 52. North America Proton Pump Inhibitors Sales by Country (2022-2027) & (M Unit)
  • Table 53. North America Proton Pump Inhibitors Revenue by Country (2016-2021) & (US$ Million)
  • Table 54. North America Proton Pump Inhibitors Revenue by Country (2022-2027) & (US$ Million)
  • Table 55. Europe Proton Pump Inhibitors Sales by Type (2016-2021) & (M Unit)
  • Table 56. Europe Proton Pump Inhibitors Sales by Type (2022-2027) & (M Unit)
  • Table 57. Europe Proton Pump Inhibitors Revenue by Type (2016-2021) & (US$ Million)
  • Table 58. Europe Proton Pump Inhibitors Revenue by Type (2022-2027) & (US$ Million)
  • Table 59. Europe Proton Pump Inhibitors Revenue by Application (2016-2021) & (US$ Million)
  • Table 60. Europe Proton Pump Inhibitors Revenue by Application (2022-2027) & (US$ Million)
  • Table 61. Europe Proton Pump Inhibitors Sales by Country (2016-2021) & (M Unit)
  • Table 62. Europe Proton Pump Inhibitors Sales by Country (2022-2027) & (M Unit)
  • Table 63. Europe Proton Pump Inhibitors Revenue by Country (2016-2021) & (US$ Million)
  • Table 64. Europe Proton Pump Inhibitors Revenue by Country (2022-2027) & (US$ Million)
  • Table 65. Asia Pacific Proton Pump Inhibitors Sales by Type (2016-2021) & (M Unit)
  • Table 66. Asia Pacific Proton Pump Inhibitors Sales by Type (2022-2027) & (M Unit)
  • Table 67. Asia Pacific Proton Pump Inhibitors Revenue by Type (2016-2021) & (US$ Million)
  • Table 68. Asia Pacific Proton Pump Inhibitors Revenue by Type (2022-2027) & (US$ Million)
  • Table 69. Asia Pacific Proton Pump Inhibitors Revenue by Application (2016-2021) & (US$ Million)
  • Table 70. Asia Pacific Proton Pump Inhibitors Revenue by Application (2022-2027) & (US$ Million)
  • Table 71. Asia Pacific Proton Pump Inhibitors Sales by Region (2016-2021) & (M Unit)
  • Table 72. Asia Pacific Proton Pump Inhibitors Sales by Region (2022-2027) & (M Unit)
  • Table 73. Asia Pacific Proton Pump Inhibitors Revenue by Region (2016-2021) & (US$ Million)
  • Table 74. Asia Pacific Proton Pump Inhibitors Revenue by Region (2022-2027) & (US$ Million)
  • Table 75. South America Proton Pump Inhibitors Sales by Type (2016-2021) & (M Unit)
  • Table 76. South America Proton Pump Inhibitors Sales by Type (2022-2027) & (M Unit)
  • Table 77. South America Proton Pump Inhibitors Revenue by Type (2016-2021) & (US$ Million)
  • Table 78. South America Proton Pump Inhibitors Revenue by Type (2022-2027) & (US$ Million)
  • Table 79. South America Proton Pump Inhibitors Revenue by Application (2016-2021) & (US$ Million)
  • Table 80. South America Proton Pump Inhibitors Revenue by Application (2022-2027) & (US$ Million)
  • Table 81. South America Proton Pump Inhibitors Sales by Country (2016-2021) & (M Unit)
  • Table 82. South America Proton Pump Inhibitors Sales by Country (2022-2027) & (M Unit)
  • Table 83. South America Proton Pump Inhibitors Revenue by Country (2016-2021) & (US$ Million)
  • Table 84. South America Proton Pump Inhibitors Revenue by Country (2022-2027) & (US$ Million)
  • Table 85. Middle East and Africa Proton Pump Inhibitors Sales by Type (2016-2021) & (M Unit)
  • Table 86. Middle East and Africa Proton Pump Inhibitors Sales by Type (2022-2027) & (M Unit)
  • Table 87. Middle East and Africa Proton Pump Inhibitors Revenue by Type (2016-2021) & (US$ Million)
  • Table 88. Middle East and Africa Proton Pump Inhibitors Revenue by Type (2022-2027) & (US$ Million)
  • Table 89. Middle East and Africa Proton Pump Inhibitors Revenue by Application (2016-2021) & (US$ Million)
  • Table 90. Middle East and Africa Proton Pump Inhibitors Revenue by Application (2022-2027) & (US$ Million)
  • Table 91. Middle East and Africa Proton Pump Inhibitors Sales by Country (2016-2021) & (M Unit)
  • Table 92. Middle East and Africa Proton Pump Inhibitors Sales by Country (2022-2027) & (M Unit)
  • Table 93. Middle East and Africa Proton Pump Inhibitors Revenue by Country (2016-2021) & (US$ Million)
  • Table 94. Middle East and Africa Proton Pump Inhibitors Revenue by Country (2022-2027) & (US$ Million)
  • Table 95. Takeda Corporation Information
  • Table 96. Takeda Description and Major Businesses
  • Table 97. Takeda Proton Pump Inhibitors Sales (M Unit), Revenue (US$ Million), Price (USD/Unit) and Gross Margin (2019-2021)
  • Table 98. Takeda Proton Pump Inhibitors Product
  • Table 99. Takeda Recent Developments
  • Table 100. Pfizer Corporation Information
  • Table 101. Pfizer Description and Major Businesses
  • Table 102. Pfizer Proton Pump Inhibitors Sales (M Unit), Revenue (US$ Million), Price (USD/Unit) and Gross Margin (2019-2021)
  • Table 103. Pfizer Proton Pump Inhibitors Product
  • Table 104. Pfizer Recent Developments
  • Table 105. AstraZeneca Corporation Information
  • Table 106. AstraZeneca Description and Major Businesses
  • Table 107. AstraZeneca Proton Pump Inhibitors Sales (M Unit), Revenue (US$ Million), Price (USD/Unit) and Gross Margin (2019-2021)
  • Table 108. AstraZeneca Proton Pump Inhibitors Product
  • Table 109. AstraZeneca Recent Developments
  • Table 110. Bayer Corporation Information
  • Table 111. Bayer Description and Major Businesses
  • Table 112. Bayer Proton Pump Inhibitors Sales (M Unit), Revenue (US$ Million), Price (USD/Unit) and Gross Margin (2019-2021)
  • Table 113. Bayer Proton Pump Inhibitors Product
  • Table 114. Bayer Recent Developments
  • Table 115. Sun Pharma Corporation Information
  • Table 116. Sun Pharma Description and Major Businesses
  • Table 117. Sun Pharma Proton Pump Inhibitors Sales (M Unit), Revenue (US$ Million), Price (USD/Unit) and Gross Margin (2019-2021)
  • Table 118. Sun Pharma Proton Pump Inhibitors Product
  • Table 119. Teva Corporation Information
  • Table 120. Teva Description and Major Businesses
  • Table 121. Teva Proton Pump Inhibitors Sales (M Unit), Revenue (US$ Million), Price (USD/Unit) and Gross Margin (2019-2021)
  • Table 122. Teva Proton Pump Inhibitors Product
  • Table 123. Teva Recent Developments
  • Table 124. Eisai Co. Corporation Information
  • Table 125. Eisai Co. Description and Major Businesses
  • Table 126. Eisai Co. Proton Pump Inhibitors Sales (M Unit), Revenue (US$ Million), Price (USD/Unit) and Gross Margin (2019-2021)
  • Table 127. Eisai Co. Proton Pump Inhibitors Product
  • Table 128. Mylan Corporation Information
  • Table 129. Mylan Description and Major Businesses
  • Table 130. Mylan Proton Pump Inhibitors Sales (M Unit), Revenue (US$ Million), Price (USD/Unit) and Gross Margin (2019-2021)
  • Table 131. Mylan Proton Pump Inhibitors Product
  • Table 132. Mylan Recent Developments
  • Table 133. AOSAIKANG Pharma Corporation Information
  • Table 134. AOSAIKANG Pharma Description and Major Businesses
  • Table 135. AOSAIKANG Pharma Proton Pump Inhibitors Sales (M Unit), Revenue (US$ Million), Price (USD/Unit) and Gross Margin (2019-2021)
  • Table 136. AOSAIKANG Pharma Proton Pump Inhibitors Product
  • Table 137. Luoxin Pharma Corporation Information
  • Table 138. Luoxin Pharma Description and Major Businesses
  • Table 139. Luoxin Pharma Proton Pump Inhibitors Sales (M Unit), Revenue (US$ Million), Price (USD/Unit) and Gross Margin (2019-2021)
  • Table 140. Luoxin Pharma Proton Pump Inhibitors Product
  • Table 141. Luoxin Pharma Recent Developments
  • Table 142. LIVZON Corporation Information
  • Table 143. LIVZON Description and Major Businesses
  • Table 144. LIVZON Proton Pump Inhibitors Sales (M Unit), Revenue (US$ Million), Price (USD/Unit) and Gross Margin (2019-2021)
  • Table 145. LIVZON Proton Pump Inhibitors Product
  • Table 146. Eastchina Pharma Corporation Information
  • Table 147. Eastchina Pharma Description and Major Businesses
  • Table 148. Eastchina Pharma Proton Pump Inhibitors Sales (M Unit), Revenue (US$ Million), Price (USD/Unit) and Gross Margin (2019-2021)
  • Table 149. Eastchina Pharma Proton Pump Inhibitors Product
  • Table 150. Key Raw Materials Lists
  • Table 151. Raw Materials Key Suppliers Lists
  • Table 152. Proton Pump Inhibitors Distributors List
  • Table 153. Proton Pump Inhibitors Customers List
  • Table 154. Proton Pump Inhibitors Market Trends
  • Table 155. Proton Pump Inhibitors Market Drivers
  • Table 156. Proton Pump Inhibitors Market Challenges
  • Table 157. Proton Pump Inhibitors Market Restraints
  • Table 158. Research Programs/Design for This Report
  • Table 159. Key Data Information from Secondary Sources
  • Table 160. Key Data Information from Primary Sources

List of Figures

  • Figure 1. Proton Pump Inhibitors Product Picture
  • Figure 2. Global Proton Pump Inhibitors Market Share by Type in 2020
  • Figure 3. Global Proton Pump Inhibitors Market Share by Type in 2027
  • Figure 4. Dexlansoprazole Product Picture
  • Figure 5. Esomeprazole Product Picture
  • Figure 6. Lansoprazole Product Picture
  • Figure 7. Omeprazole Product Picture
  • Figure 8. Pantoprazole Product Picture
  • Figure 9. Rabeprazole Product Picture
  • Figure 10. Global Proton Pump Inhibitors Market Share by Application in 2020
  • Figure 11. Global Proton Pump Inhibitors Market Share by Application in 2027
  • Figure 12. Hospital Pharmacy
  • Figure 13. Retail Pharmacy
  • Figure 14. Proton Pump Inhibitors Report Years Considered
  • Figure 15. Global Proton Pump Inhibitors Sales 2016-2027 (M Unit)
  • Figure 16. Global Proton Pump Inhibitors Revenue, (US$ Million), 2016 VS 2021 VS 2027
  • Figure 17. Global Proton Pump Inhibitors Revenue 2016-2027 (US$ Million)
  • Figure 18. Global Proton Pump Inhibitors Revenue Market Share by Region in Percentage: 2020
  • Figure 19. Global Proton Pump Inhibitors Revenue Market Share by Region in Percentage: 2027
  • Figure 20. North America Proton Pump Inhibitors Sales YoY (2016-2027) & (M Unit)
  • Figure 21. North America Proton Pump Inhibitors Revenue YoY (2016-2027) & (US$ Million)
  • Figure 22. Europe Proton Pump Inhibitors Sales YoY (2016-2027) & (M Unit)
  • Figure 23. Europe Proton Pump Inhibitors Revenue YoY (2016-2027) & (US$ Million)
  • Figure 24. Asia-Pacific Proton Pump Inhibitors Sales YoY (2016-2027) & (M Unit)
  • Figure 25. Asia-Pacific Proton Pump Inhibitors Revenue YoY (2016-2027) & (US$ Million)
  • Figure 26. South America Proton Pump Inhibitors Sales YoY (2016-2027) & (M Unit)
  • Figure 27. South America Proton Pump Inhibitors Revenue YoY (2016-2027) & (US$ Million)
  • Figure 28. Middle East & Africa Proton Pump Inhibitors Sales YoY (2016-2027) & (M Unit)
  • Figure 29. Middle East & Africa Proton Pump Inhibitors Revenue YoY (2016-2027) & (US$ Million)
  • Figure 30. The Top 5 Players Market Share by Proton Pump Inhibitors Sales in 2020
  • Figure 31. The Top 5 Players Market Share by Proton Pump Inhibitors Revenue in 2020
  • Figure 32. Global Proton Pump Inhibitors Sales Market Share by Type (2016-2027)
  • Figure 33. Global Proton Pump Inhibitors Revenue Market Share by Type (2016-2027)
  • Figure 34. Global Proton Pump Inhibitors Sales Market Share by Application (2016-2027)
  • Figure 35. Global Proton Pump Inhibitors Revenue Market Share by Application (2016-2027)
  • Figure 36. North America Proton Pump Inhibitors Sales Market Share by Type (2016-2027)
  • Figure 37. North America Proton Pump Inhibitors Revenue Market Share by Type (2016-2027)
  • Figure 38. North America Proton Pump Inhibitors Revenue Market Share by Application (2016-2027)
  • Figure 39. North America Proton Pump Inhibitors Sales Share by Country (2016-2027)
  • Figure 40. North America Proton Pump Inhibitors Revenue Share by Country (2016-2027)
  • Figure 41. United States Proton Pump Inhibitors Revenue (2016-2027) & (US$ Million)
  • Figure 42. Canada Proton Pump Inhibitors Revenue (2016-2027) & (US$ Million)
  • Figure 43. Mexico Proton Pump Inhibitors Revenue (2016-2027) & (US$ Million)
  • Figure 44. Europe Proton Pump Inhibitors Sales Market Share by Type (2016-2027)
  • Figure 45. Europe Proton Pump Inhibitors Revenue Market Share by Type (2016-2027)
  • Figure 46. Europe Proton Pump Inhibitors Revenue Market Share by Application (2016-2027)
  • Figure 47. Europe Proton Pump Inhibitors Sales Share by Country (2016-2027)
  • Figure 48. Europe Proton Pump Inhibitors Revenue Share by Country (2016-2027)
  • Figure 49. Germany Proton Pump Inhibitors Revenue (2016-2027) & (US$ Million)
  • Figure 50. U.K. Proton Pump Inhibitors Revenue (2016-2027) & (US$ Million)
  • Figure 51. France Proton Pump Inhibitors Revenue (2016-2027) & (US$ Million)
  • Figure 52. Italy Proton Pump Inhibitors Revenue (2016-2027) & (US$ Million)
  • Figure 53. Russia Proton Pump Inhibitors Revenue (2016-2027) & (US$ Million)
  • Figure 54. Asia Pacific Proton Pump Inhibitors Sales Market Share by Type (2016-2027)
  • Figure 55. Asia Pacific Proton Pump Inhibitors Revenue Market Share by Type (2016-2027)
  • Figure 56. Asia Pacific Proton Pump Inhibitors Revenue Market Share by Application (2016-2027)
  • Figure 57. Asia Pacific Proton Pump Inhibitors Sales Share by Region (2016-2027)
  • Figure 58. Asia Pacific Proton Pump Inhibitors Revenue Share by Region (2016-2027)
  • Figure 59. China Proton Pump Inhibitors Revenue (2016-2027) & (US$ Million)
  • Figure 60. Japan Proton Pump Inhibitors Revenue (2016-2027) & (US$ Million)
  • Figure 61. South Korea Proton Pump Inhibitors Revenue (2016-2027) & (US$ Million)
  • Figure 62. India Proton Pump Inhibitors Revenue (2016-2027) & (US$ Million)
  • Figure 63. Southeast Asia Proton Pump Inhibitors Revenue (2016-2027) & (US$ Million)
  • Figure 64. Australia Proton Pump Inhibitors Revenue (2016-2027) & (US$ Million)
  • Figure 65. South America Proton Pump Inhibitors Sales Market Share by Type (2016-2027)
  • Figure 66. South America Proton Pump Inhibitors Revenue Market Share by Type (2016-2027)
  • Figure 67. South America Proton Pump Inhibitors Revenue Market Share by Application (2016-2027)
  • Figure 68. South America Proton Pump Inhibitors Sales Share by Country (2016-2027)
  • Figure 69. South America Proton Pump Inhibitors Revenue Share by Country (2016-2027)
  • Figure 70. Brazil Proton Pump Inhibitors Revenue (2016-2027) & (US$ Million)
  • Figure 71. Middle East and Africa Proton Pump Inhibitors Revenue Market Share by Application (2016-2027)
  • Figure 72. Middle East and Africa Proton Pump Inhibitors Sales Share by Country (2016-2027)
  • Figure 73. Middle East and Africa Proton Pump Inhibitors Revenue Share by Country (2016-2027)
  • Figure 74. Turkey Proton Pump Inhibitors Revenue (2016-2027) & (US$ Million)
  • Figure 75. Saudi Arabia Proton Pump Inhibitors Revenue (2016-2027) & (US$ Million)
  • Figure 76. U.A.E Proton Pump Inhibitors Revenue (2016-2027) & (US$ Million)
  • Figure 77. Proton Pump Inhibitors Value Chain
  • Figure 78. Channels of Distribution
  • Figure 79. Distributors Profiles
  • Figure 80. Bottom-up and Top-down Approaches for This Report
  • Figure 81. Data Triangulation
  • Figure 82. Key Executives Interviewed
Back to Top